Literature DB >> 15582165

[Cold agglutinins, clinical presentation and significance; retrospective analysis of 58 patients].

M-O Chandesris1, N Schleinitz, V Ferrera, E Bernit, K Mazodier, S Gayet, J-M Chiaroni, V Veit, G Kaplanski, J-R Harlé.   

Abstract

PURPOSE: To describe clinical, biological characteristics and associated diseases of cold agglutinins in adults.
METHODS: Retrospective study in a single department of internal medicine from 1997 to 2002. The inclusion criteria were a positive direct Coombs test and a positive research for cold-reactive autoantibodies. We recorded for each patient: clinical presentation at onset and during follow-up, biological parameters of haemolysis, biological characteristics of the cold agglutinin and associated diseases.
RESULTS: Fifty-eight patients (34 females, 24 males), with medium age of 58.8 were included in the study. Clinical presentation was highly variable between acute life-threatening haemolysis and absence of symptoms. Results of direct antiglobulin test were C3 (74%), IgG + C3 (22.4%), IgG (3.4%). Titer, thermal amplitude, strength and specificity of Coombs test were correlated, in all cases except 6, with cold agglutinin haemolytic activity. In 77.6% of cases cold agglutinin was secondary; related to: autoimmune disorders (n = 19), lymphoproliferative disorders (n = 11) and infections (n = 10).
CONCLUSION: Clinical presentation of cold agglutinin is highly variable and not always related to the biological characteristics of the bound antibody (titer, thermal amplitude, specificity). In our single center study, diseases associated with cold agglutinin were various with the highest frequency of auto-immune disorders. Our study underlined also the high frequency of lymphoproliferative disorders and justifies a close follow-up of these patients. Finally, we reported a high frequency of hepatitis C virus infection among the infectious aetiologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582165     DOI: 10.1016/j.revmed.2004.08.001

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  5 in total

1.  Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings.

Authors:  Cathrin Arthold; Cathrin Skrabs; Gerlinde Mitterbauer-Hohendanner; Renate Thalhammer; Ingrid Simonitsch-Klupp; Simon Panzer; Peter Valent; Klaus Lechner; Ulrich Jäger; Christian Sillaber
Journal:  Wien Klin Wochenschr       Date:  2014-05-20       Impact factor: 1.704

Review 2.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

Review 3.  The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia.

Authors:  Mirela Raos; Marija Lukic; Drazen Pulanic; Marijo Vodanovic; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 5.752

4.  A novel method for demonstrating cold agglutinin disease: a case report.

Authors:  Thomas A Vo; Zack Oakey; Yasir A Khan; Donald S Minckler
Journal:  J Med Case Rep       Date:  2018-04-18

Review 5.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.